248 related articles for article (PubMed ID: 36321825)
1. Probiotic Bifidobacteria Mitigate the Deleterious Effects of
Stuivenberg GA; Chmiel JA; Akouris PP; Burton JP; Reid G
mSphere; 2022 Dec; 7(6):e0044622. PubMed ID: 36321825
[TBL] [Abstract][Full Text] [Related]
2. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
3. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
[TBL] [Abstract][Full Text] [Related]
4. Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease.
Dong Y; Gai Z; Han M; Xu J; Zou K
Probiotics Antimicrob Proteins; 2024 Jun; ():. PubMed ID: 38829564
[TBL] [Abstract][Full Text] [Related]
5. Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure.
Di Paola R; De A; Izhar R; Abate M; Zappavigna S; Capasso A; Perna AF; La Russa A; Capasso G; Caraglia M; Simeoni M
Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372437
[TBL] [Abstract][Full Text] [Related]
6. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
McFarlane C; Ramos CI; Johnson DW; Campbell KL
J Ren Nutr; 2019 May; 29(3):209-220. PubMed ID: 30366767
[TBL] [Abstract][Full Text] [Related]
7. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
[TBL] [Abstract][Full Text] [Related]
8. Dietary strategies for gut-derived protein-bound uremic toxins and cardio-metabolic risk factors in chronic kidney disease: A focus on dietary fibers.
Melekoglu E; Samur FG
Crit Rev Food Sci Nutr; 2023; 63(19):3994-4008. PubMed ID: 34704501
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial.
Mitrović M; Stanković-Popović V; Tolinački M; Golić N; Soković Bajić S; Veljović K; Nastasijević B; Soldatović I; Svorcan P; Dimković N
J Ren Nutr; 2023 Mar; 33(2):278-288. PubMed ID: 35995418
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
11. Microbiota issue in CKD: how promising are gut-targeted approaches?
Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
[TBL] [Abstract][Full Text] [Related]
12. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
[TBL] [Abstract][Full Text] [Related]
13. Microbiota-Mediated Modulation of Organophosphate Insecticide Toxicity by Species-Dependent Interactions with Lactobacilli in a Drosophila melanogaster Insect Model.
Daisley BA; Trinder M; McDowell TW; Collins SL; Sumarah MW; Reid G
Appl Environ Microbiol; 2018 May; 84(9):. PubMed ID: 29475860
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Synbiotic Supplementation on Uremic Toxins, Oxidative Stress, and Inflammation in Hemodialysis Patients-Results of an Uncontrolled Prospective Single-Arm Study.
Kuskunov T; Tilkiyan E; Doykov D; Boyanov K; Bivolarska A; Hristov B
Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629672
[No Abstract] [Full Text] [Related]
15. The Potential Benefits and Controversies of Probiotics Use in Patients at Different Stages of Chronic Kidney Disease.
Tian N; Li L; Ng JK; Li PK
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235699
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiome, kidney disease, and targeted interventions.
Ramezani A; Raj DS
J Am Soc Nephrol; 2014 Apr; 25(4):657-70. PubMed ID: 24231662
[TBL] [Abstract][Full Text] [Related]
17. The gut microbiota and its relationship with chronic kidney disease.
Plata C; Cruz C; Cervantes LG; Ramírez V
Int Urol Nephrol; 2019 Dec; 51(12):2209-2226. PubMed ID: 31576489
[TBL] [Abstract][Full Text] [Related]
18. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.
Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P
Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619
[TBL] [Abstract][Full Text] [Related]
19. Novel intestinal dialysis interventions and microbiome modulation to control uremia.
Sumida K; Lau WL; Kalantar-Zadeh K; Kovesdy CP
Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):82-91. PubMed ID: 34846313
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease.
Steenbeke M; Valkenburg S; Gryp T; Van Biesen W; Delanghe JR; Speeckaert MM; Glorieux G
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
